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Abstract
Background: Although Venezuela has a National Human Immunodeficiency Virus (HIV) Program
offering free diagnosis and treatment, 41% of patients present for diagnosis at a later disease-stage,
indicating that access to care may still be limited. Our study aimed to identify factors influencing
delay in presenting for HIV-diagnosis using a case-case comparison. A cross-sectional survey was
performed at the Regional HIV Reference Centre (CAI), Carabobo Region, Venezuela. Between
May 2005 and October 2006 225 patients diagnosed with HIV at CAI were included and
demographic, behavioural and medical characteristics collected from medical files. Socio-economic
and behavioural factors were obtained from 129 eligible subjects through interviews. "Late
presentation" at diagnosis was defined as patients classified with disease-stage B or C according to
the 1993 Centers for Disease Control and Prevention (Atlanta, USA) classification, and "early
presentation" defined as diagnosis in disease-stage A.
Results: Of 225 subjects, 91 (40%) were defined as late presenters. A similar proportion (51/129)
was obtained in the interviewed sub-sample. Older age (>30 years), male heterosexuality, lower
socio-economic status, perceiving ones partner to be faithful and living ≥ 25 km from the CAI were
positively associated with late diagnosis in a multivariate model. Females were less likely to present
late than heterosexual males (odds ratio = 0.23, P = 0.06). The main barriers to HIV testing were
low knowledge of HIV/AIDS, lack of awareness of the free HIV program, lack of perceived risk of
HIV-infection, fear for HIV-related stigma, fear for lack of confidentiality at testing site and logistic
barriers.
Conclusion: Despite the free Venezuelan HIV Program, poverty and barriers related to lack of
knowledge and awareness of both HIV and the Program itself were important determinants in late
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presentation at HIV diagnosis. This study also indicates that women; heterosexual, bisexual and
homosexual men might have different pathways to testing and different factors related to late
presentation in each subgroup. Efforts must be directed to i) increase awareness of HIV/AIDS and
the Program and ii) the identification of specific factors associated with delay in HIV diagnosis per
subgroup, to help develop targeted public health interventions improving early diagnosis and
prognosis of people living with HIV/AIDS in Venezuela and elsewhere.
Background
With an estimated 110,000 people living with Human
Immunodeficiency Virus (HIV)/Acquired Immune Defi-
ciency Syndrome (AIDS) (PLWHA) in 2005, Venezuela is
among the countries with the highest HIV prevalence
(0.7% in adults) in Latin America [1]. The ratio men to
women gradually changed from 19:1 in the eighties to 2:1
in 2004 [2]. As in the rest of Latin America, HIV is mostly
spread through sexual transmission, accounting for 90%
of all reported HIV-infections between 1982 and 1999 [3].
Of the reported sexual transmissions of HIV 65% in that
period involved men who had sex with men [3]. However,
as the epidemic matures the proportion of infected heter-
osexual men and women is rising [2]. Analyses of data col-
lected from 1999 to 2004 in Carabobo State showed that
heterosexual transmission occurred in 61% of the cases
[4].
Since 1999, the Venezuelan National HIV/AIDS Program
(PNSIDA in Spanish) provides free comprehensive care
for PLWHA, including diagnosis and monitoring, antiret-
roviral therapy (ART), treatment of opportunistic infec-
tions and other sexually transmitted infections (STIs), and
prevention of mother-to-child transmission [5]. In 2005,
almost 16,000 PLWHA received free ART [2]. However, of
those estimated to require treatment in Venezuela in
2005, 16% did not receive it [6]. A recent study in Cara-
bobo State found that 41% (196/491) of the HIV-infected
patients attending the PNSIDA between 1999–2004 pre-
sented for diagnosis at a later disease stage [4]. This indi-
cates that there are other factors hindering access to HIV-
care than cost of diagnosis and treatment.
Early diagnosis of HIV-infection has benefits for the
patient, public health and the society as a whole. Patients
diagnosed at a late stage have poorer prognosis [7],
whereas when started early, ART is more effective [8-11]
and with early diagnosis psychosocial aspects can be bet-
ter dealt with [12]. Early diagnosis also reduces HIV-trans-
mission through clinical and behavioural preventive
measures [13,14]. Finally, the early detection of HIV-
infection has proven to be economically beneficial
[15,16] and to improve healthcare system planning capa-
bilities [17].
Few studies have focused on these issues in Latin America
[18,19]. A high proportion of individuals in Venezuela
discover they are HIV-infected too late to fully benefit
from ART. However, little research has been performed on
the impact of government HIV programmes and the
knowledge and behaviour of the targeted populations
[20]. Here we report the identification of factors associ-
ated with late presentation at HIV-diagnosis concomi-
tantly with perceived barriers to testing in Venezuela. We
furthermore highlight the importance of understanding
region-specific determinants in order to improve the
impact of free HIV-programs.
Results
Between the 1st of May 2005 and the 31st of October
2006, 226 individuals were newly diagnosed with HIV at
the Reference Centre for Sexually Transmitted Infections
and HIV/AIDS (CAI, in Spanish) in Valencia, Carabobo
region, Venezuela. One individual was excluded from the
study as the patient's medical file could not be located.
The outcome of interest, 'late presentation' (disease stage
B or C at HIV-diagnosis [21]), occurred in 40% (91/225)
of the individuals in agreement with a previous study [4].
Of the 225 included individuals, 129 (57%) were inter-
viewed between the 25th of April and the 25th of October
2006. Of the 96 remaining eligible subjects one died, a
second moved away, a third could not answer the ques-
tionnaire and three refused to participate; a further 90
were not interviewed either because they never attended
the clinic during the study period, or because the inter-
viewers were not available when they did. The average
time between HIV diagnosis and interview was 4 months.
Data collected from the patients' medical files was used to
describe the total study population (n = 225). To test how
representative the interviewed sample was, possible differ-
ences between the interviewed (n = 129) and non-inter-
viewed individuals (n = 96) were examined by comparing
the distribution of age, sex, marital status, education level,
occupation, sexual orientation, HIV disease-stage classifi-
cation [21], CD4+ count, number of casual partners, con-
dom and alcohol use and drug abuse between the two
groups at the moment of HIV diagnosis (data not shown).
There were no statistically significant differences except
for sexual orientation, where a lower proportion of male
heterosexuals was interviewed (26% vs. 47%; P = 0.001).AIDS Research and Therapy 2008, 5:6 http://www.aidsrestherapy.com/content/5/1/6
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Demographic, socio-economic and behavioural factors
The mean age was 33 years (range 15–79 years) with the
majority (67%) of individuals between 20 and 40 years
old and a male/female ratio of nearly 4:1 (Table 1). Most
of the single (111/132) and married persons (11/15) were
men, while half (32/60) of the unmarried people living
with a partner were women. Only 3 females self-identified
as homo- or bisexual. Bi- and homosexuals were more
likely to have finished secondary school than heterosexu-
als (70% vs. 33%; P < 0.001).
Table 1: Demographic and socio-economic factors associated with late presentation at HIV diagnosis in Venezuela, Carabobo State.
Late presenters Total
n% n O R *(95%CI) P-value (PT)
SOCIO-DEMOGRAPHIC
Sexa, †
Male 72 44.2 163 1 -
Female 19 30.6 62 0.57 (0.30–1.10) 0.094
Age (years)a,‡
< 20 3 17.6 17 1 -      (0.003)
20–29 24 27.0 89 1.74 (0.46–6.64) 0.417
30–39 34 55.7 61 6.02 (1.56–23.30) 0.009
>40 30 51.7 58 4.86 (1.25–18.84) 0.022
Marital Statusa (n = 224)
Single 54 40.9 132 1 -
Married 9 47.4 19 1.06 (0.38–2.95) 0.912
Divorced 6 75.0 8 3.06 (0.56–16.77) 0.198
Widowed 2 40.0 5 0.69 (0.11–4.48) 0.693
Living together 20 33.3 60 0.86 (0.42–1.74) 0.670
Childrena (n = 219)
03 5 3 2 . 1 1 0 9 1 -
≥ 1 52 47.3 110 2.06 (1.11–3.83) 0.022
Sexual orientationa
Heterosexual 60 43.5 138 1 -
Bisexual 17 47.2 36 0.76 (0.33–1.71) 0.503
Homosexual 14 27.5 51 0.40 (0.18–0.87) 0.020
Education levela
Not finished secondary school 55 46.6 118 1 -
Secondary school and higher 36 33.6 107 0.57 (0.32–1.01) 0.053
SOCIO-ECONOMIC
Type of occupationa (n = 223)
Unemployed 8 42.1 19 1 -
Domestic worker 11 35.5 31 2.35 (0.54–10.28) 0.258
Manual worker 25 56.8 44 1.73 (0.55–5.46) 0.347
Self-employed/Commerce 22 50.0 44 1.41 (0.45–4.44) 0.555
Paid employee/Office worker 14 27.5 51 0.57 (0.18–1.79) 0.334
Professional/University staff 4 33.3 12 0.53 (0.11–2.55) 0.426
Student 7 31.8 22 1.38 (0.35–5.52) 0.646
Area of residenceb
Rural 8 57.1 14 1 -
Urban 43 37.4 115 0.34 (0.10–1.15) 0.082
Ownership residenceb
Owning 37 50.0 74 1 - (0.008)
Renting 8 26.7 30 0.30 (0.11–0.81) 0.017
Borrow/lodged 6 24.0 25 0.38 (0.13–1.10) 0.074
Socio-economic statusb,§
Low 32 50.0 64 1
High 19 29.2 65 0.24 (0.10–0.57) 0.001
aData source: patient files (n = 225). bData source: questionnaires (n = 129). Missing values are deducted by subtracting the total of individuals for 
each variable to the corresponding 225 (a) or 129 (b) patients. If totals are not indicated for a variable, it has no missing values. *Adjusted for age 
group and sex. †Odds ratio only adjusted for age group. ‡Odds ratio only adjusted for sex. §Socio-economic status was calculated for all interviewed 
persons as described in Methods. OR, odds ratio; CI, confidence interval; PT, Mantel-Haenszel Score test for trend P-value.AIDS Research and Therapy 2008, 5:6 http://www.aidsrestherapy.com/content/5/1/6
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Older age (≥ 30 years), having children and lower educa-
tion level showed a significant positive association with
late presentation for HIV-testing (Table 1). Women were
almost half as likely to present late as men, while homo-
sexuals were less likely to present late than heterosexuals.
Although socio-economic factors did not show a clear
association except for ownership of residence, the com-
pound variable "Socio-economic status" (SES, see Meth-
ods) indicated that individuals with lower SES were more
likely to be late presenters at HIV-diagnosis (Table 1).
Late presentation was not associated with alcohol con-
sumption, drug abuse or condom use. The proportion of
late presenters was lower among those having a steady
partner, however this effect was mostly found for those
who knew their steady partner was HIV-infected (Table 2).
Moreover, perceiving their steady partner to be unfaithful,
which could be a proxy for risk perception, showed a neg-
ative association with late presentation. There was an
increased trend to present late the longer a person had a
steady partner (Table 2).
Knowledge of HIV/AIDS
The majority of interviewed people (125/129) indicated
they had heard about HIV. The main sources of informa-
tion were the media, family/friends and school. Most peo-
ple (118/129) said they knew how HIV was transmitted.
Awareness of the existence of an HIV control program was
low. Most people knew that an HIV-test existed but 59%
(68/115) of these were not aware that the test was freely
available (Table 2). Among the latter, 53% did not know
how much a test would cost. Fewer people knew that treat-
ment existed and only 25 knew it was available for free
(Table 2).
Individuals who had never heard of HIV were more likely
to be late at diagnosis than those who had (50% vs. 39%),
but this effect was not significant (P = 0.662), possibly due
to small sample size in the first group (n = 4, data not
shown). Having heard about HIV at school decreased the
likelihood of late presentation (OR, 0.39; 95% confidence
interval (CI), 0.15–1.01), while none of the other sources
of information showed any effect (data not shown). There
was a decreasing trend for late presentation with increas-
ing knowledge of HIV-transmission and awareness of the
PNSIDA (Table 2). Awareness of existence and free availa-
bility of HIV testing was negatively associated with late
presentation while no association was found for aware-
ness of treatment availability. Persons with a low total-
HIV-knowledge score were twice as likely to present late (P
= 0.096, Table 2).
Risk perception and barriers and facilitators for testing
More than half of the interviewees had felt at risk of HIV-
infection before diagnosis (Table 3). The main reasons
mentioned for this risk perception were having unpro-
tected sex (n = 21), having many sexual partners (n = 21),
having homosexual partners (n = 10), having an unfaith-
ful partner (n = 7), and having an HIV-positive partner (n
= 7). The main reasons mentioned for not feeling at risk
were having a steady partner (n = 25), not being aware of
their own risk behaviour (n = 18), not knowing about HIV
(n = 10), having protected sexual intercourse (n = 8), and
not having any symptoms (n = 7). The time span people
felt at risk before HIV-diagnosis ranged from 1 month to
12 years, with a geometric mean of 10 months. Of those
who felt at risk, almost half (31/67) indicated no health-
seeking behaviour, 16 (24%) started protecting them-
selves or turned to family, friends or their partner for
advice, and 18 (27%) went to a health centre or the CAI.
The majority of the interviewed persons (71/129) indi-
cated to have perceived no barriers to HIV-testing. This
may in part be explained by lack of perception of risk for
HIV-infection, since those who had felt at risk were 7
times more likely to have mentioned any barriers (P <
0.001). Fourteen individuals (11%) mentioned at least
one of the barriers categorized under 'confidentiality test-
ing site,' while 32 individuals (25%) mentioned barriers
from the category 'fear for stigma' and 12 (9%) mentioned
items indicating logistical barriers (see Methods for defi-
nitions of categories).
Although not significant, late presentation was slightly
higher among those that had not felt at risk of HIV-infec-
tion than those who did when the question "did you feel
at risk" was asked directly. However, mentioning not to
have perceived themselves to be at risk as a barrier to HIV-
testing showed a strong association with late presentation,
even after adjusting for age group and sex (Table 3). Peo-
ple who had perceived barriers to HIV-testing were more
likely to present late but this effect was not significant (P
= 0.344). For the categories of barriers 'fear for stigma' and
'confidentiality testing site' a similar non significant asso-
ciation was found. Persons indicating logistical constrains
were almost 4 times more likely to present late (P = 0.042;
Table 3). Mentioning not-wanting-to-know their HIV sta-
tus was associated with late presentation (Table 3), while
mentioning fear to be diagnosed positive was not (OR,
1.00; 95%CI 0.39–2.59), indicating that this might have a
bi-directional effect on testing behaviour. Of the 13 per-
sons that presented late and mentioned not-having-symp-
toms-yet as a barrier, 9 (69%) had felt at risk, indicating
that feeling healthy might prevent people from converting
their perception of risk into the act of HIV-testing. Persons
living ≥ 25 km away from the CAI were 3 times more likely
to present late than those who did not(Table 3). However,
reported time and transport costs to CAI were not associ-
ated with late presentation.AIDS Research and Therapy 2008, 5:6 http://www.aidsrestherapy.com/content/5/1/6
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Table 2: Behavioural characteristics and knowledge attributes associated with late presentation at HIV diagnosis in Venezuela, 
Carabobo State.
Late presenters Total
n% n O R *(95%CI) P-value (PT)
BEHAVIOURAL CHARACTERISTICS
Alcohol usea (n = 221)
No alcohol 32 47.1 68 1 -
Social drinker 33 34.0 97 0.49 (0.25–0.97) 0.041
Moderate drinker 18 39.1 46 0.55 (0.24–1.25) 0.155
Alcoholic 7 70.0 10 1.61 (0.35–7.44) 0.541
Drug abusea (n = 215)
No 82 42.1 195 1 -
Yes 8 40.0 20 0.91 (0.34–2.44) 0.855
Lifetime casual partnersb (n = 114)
0 8 28.6 28 1 -      (0.286)
1–10 16 34.8 46 1.66 (0.40–6.97) 0.489
>10 21 47.5 40 2.72 (0.60–12.48) 0.197
Steady partnera (n = 219)
No 52 48.6 107 1 -      (0.021)
Yes, partner HIV- or unknown HIV status 25 40.3 62 0.66 (0.16–2.65) 0.558
Yes, partner HIV+ 12 24.0 50 0.42 (0.19–0.92) 0.030
Perception faithfulness steady partnerb
Faithful 23 56.1 41 1 -
Unfaithful/Doubting faithfulness 4 16.0 25 0.18 (0.05–0.66) 0.010
No steady partner 24 38.1 63 0.49 (0.21–1.12) 0.094
Time with steady partner (months)a, † (n = 106)
<24 10 20.8 48 1 -      (0.010)
25–120 18 40.0 45 2.49 (0.95–6.52) 0.063
>120 7 53.8 13 3.01(0.75–12.15) 0.121
Condom usea (n = 169)
Never 39 38.2 102 1 -
Sometimes 13 36.1 36 0.95 (0.40–2.26) 0.911
Often 7 38.9 18 0.96 (0.32–2.94) 0.946
Always 6 46.2 13 0.71 (0.21–2.41) 0.583
Contact with commercial sex workersb,‡ (n = 93)
No 22 34.4 64 1 -
Yes 18 62.1 29 2.54 (0.99–6.54) 0.054
KNOWLEDGE ATTRIBUTES
Knowledge-HIV-transmission scoreb,§
0 = no knowledge 7 63.6 11 1 -      (0.033)
1–8 = poor knowledge 9 56.3 16 0.94 (0.18–5.03) 0.944
9–15 = good knowledge 35 34.3 102 0.32 (0.08–1.26) 0.103
Awareness HIV testb
Not aware of existence 9 64.3 14 1 -      (0.089)
Aware of existence, but not aware it was for free 26 38.2 68 0.39 (0.11–1.38) 0.143
Aware of existence and that it was for free 16 34.0 47 0.31 (0.08–1.14) 0.078
Awareness treatmentb
Not aware of existence 24 40.0 60 1 -
Aware of existence, but not aware it was for free 15 34.1 44 0.79 (0.34–1.84) 0.580
Aware of existence and that it was for free 12 48.0 25 1.03 (0.37–2.86) 0.951
Awareness PNSIDA scoreb, ** (n = 128)
0 = no awareness 7 63.6 11 1 -      (0.055)
1–4 = some awareness 37 38.5 96 0.32 (0.08–1.29) 0.109
5–7 = good awareness 7 33.3 21 0.20 (0.04–1.05) 0.057
Total-HIV-knowledge scoreb,†† (n = 128)
0–14 = low overall knowledge 20 51.3 39 1 -
15–28 = high overall knowledge 31 34.8 89 0.51 (0.23–1.13) 0.096
aData source: patient files (n = 225). bData source: questionnaires (n = 129). Missing values are deducted by subtracting the total of individuals for each variable to the 
corresponding 225 (a) or 129 (b) patients. If totals are not indicated for a variable, it has no missing values. *Adjusted for age group and sex. †Only those with steady partner 
were included (n = 112). ‡Only men were included (n = 94). §Calculated from a 15-item HIV transmission question. **Calculated by adding all awareness variables. 
††Calculated by adding knowledge HIV transmission score, awareness PNSIDA score and one point for each correct answer to 6 true-or-false statements about HIV/AIDS. 
OR, odds ratio; CI, confidence interval; PT, Mantel-Haenszel Score test for trend P-value.AIDS Research and Therapy 2008, 5:6 http://www.aidsrestherapy.com/content/5/1/6
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Taking the HIV-test on their own initiative (50/129) or for
health-related reasons (47/129) were mentioned by most
individuals, while the remaining 32 individuals men-
tioned screening as the reason for testing. Testing on own
initiative was negatively associated with late presentation
(OR, 0.44; CI, 0.21–0.94), while testing for health-related
reasons increased the likelihood of being late 8 times (P <
0.001, Figure 1). Of those tested as part of screening, 13%
was still diagnosed in a late stage of HIV-infection.
Multivariate analysis
For a final model, sexual orientation and sex were com-
bined into one variable ('sexuality') with women, hetero-
sexual men, homosexual men and bisexual men as the
four categories. Persons living <25 km away from the CAI,
of younger age, that did not perceive their partner to be
faithful and women and homosexual men remained less
likely to present late after adjusting for SES, having an
HIV+ partner, overall HIV knowledge, and screening as
reason for testing (Table 3).
Discussion
This study is, to our knowledge, the first in Latin America
to have explored factors associated with late presentation
at HIV-diagnosis concomitantly with perceived barriers to
testing. Only two other studies have been performed in
Latin America; a study in French Guiana examined deter-
minants of late HIV-diagnosis [19] and another in Brazil
looked at barriers to testing during antenatal care [18]. In
developed and Sub-Saharan African countries, most stud-
ies either focus on perceived barriers and attitudes to vol-
untary testing [22-25] or on determinants of late
presentation for HIV-testing [10,26-29]. Few studies have
actually examined the pathway – and hurdles – of those
who present late for HIV-diagnosis, and most of them
were carried out in developed countries [30-32]. Using a
case-case comparison this study has identified factors
involved with late presentation for HIV-diagnosis within
a free HIV-program in Latin America. In line with other
studies examining HIV-testing behaviour and late presen-
tation, we have found that older age [7,10,19,26,33],
lower educational level [18,27], lower SES [28] and heter-
osexual orientation in men [10,12,28] increase the likeli-
hood of late presentation. Moreover, lack of knowledge
about HIV/AIDS [34], lack of awareness about the free
services provided by the PNSIDA, lack of perceived risk of
infection [23,24,28,35], psychological barriers
[23,25,28,34-36] and logistical constraints [23,24,36] are
associated with this delay in HIV-testing.
Since it is difficult to determine the moment of infection,
low CD4+-cell count at diagnosis [19,26,29,30] or rapid
progression to AIDS [10,27,28,31,37] have been used to
define late presentation. In contrast, we used the CDC
classification system for HIV-infection [21] encompassing
the whole clinical picture at the moment of diagnosis
which allowed the inclusion of all individuals newly diag-
nosed within the period of study. Our case definition was
deliberately chosen to avoid ascertainment bias in our
study population since around 60% of individuals do not
have a CD4 count up to at least three months after HIV
diagnosis [4]. Moreover, differential distribution of indi-
viduals without CD4 counts introduces further bias, as the
majority of patients without CD4 counts represent dis-
ease-stage A patients. A limitation of our study is that only
57% of the study population could be interviewed. These
individuals had a lower proportion of male heterosexuals
than non-interviewed. Heterosexual men may be more
reluctant to be interviewed than bisexual or homosexual
men especially if the latter feel supported by dedicated
NGOs making them more open to discuss their HIV sta-
tus. Other possible limitations refer to recall bias as most
questions related to the time before or at diagnosis, and
bias due to the setting of the interview, since respondents
might have been reluctant to mention barriers related to
the CAI when the interview was conducted by the clinic's
staff. However, we tried to minimise these by proper train-
ing of interviewers and by ascertaining that the interview-
ees' answers referred to the appropriate time before or at
diagnosis. The use of a case-case comparison minimises
differential recall bias that may occur in case-control stud-
ies [38]. The CAI is the reference centre for the regional
PNSIDA but it is possible that very ill patients may be
admitted directly to tertiary hospitals. In this case, these
patients are either reported to CAI after HIV diagnosis or,
more commonly, blood samples are sent to CAI for diag-
nosis. If any of these patients were diagnosed within the
period of our study they were also included in the sam-
pled population.
Delayed HIV diagnosis has been related with age in most
studies. While some find older age influencing late pres-
entation (this study, [7,10,19,26,33]) others find younger
individuals more at risk of a late diagnosis [27,37]. Study
design may have influenced this contrasting association
with age where exclusion criteria may have limited how
representative the study sample was as previously noted
by other authors [27,28]. Older individuals in Venezuela
may be less aware of HIV and more reluctant to come for-
ward to HIV testing compared to younger individuals.
In our study, risk perception measured by different prox-
ies showed contrasting associations with late presenta-
tion. Many studies have identified risk perception as a
motivator for HIV-testing [26,30,39]. However, it was also
found that for some people, risk perception acts as a deter-
rent for HIV-testing [17,28]. This bi-directional effect
might have distorted some of the associations with late
presentation in our study. For instance, when risk percep-
tion was asked about directly, no association could beAIDS Research and Therapy 2008, 5:6 http://www.aidsrestherapy.com/content/5/1/6
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Table 3: Risk perception, barriers to testing and final model of factors independently associated with late presentation at HIV diagnosis 
in Venezuela, Carabobo State.
Late presenters Total
n % n OR* (95%CI) P-value
PERCEPTION OF RISK
Felt at risk of HIV infection (asked directly)b
No 26 41.9 62 1 -
Yes 25 37.3 67 0.83 (0.39–1.79) 0.638
No perception of risk (mentioned as barrier)b (n = 122)
Not mentioned 36 35.0 103 1 -
Mentioned 12 63.2 19 4.33 (1.40–13.33) 0.011
Health-seeking behaviour when felt at riskb,† (n = 65)
No health-seeking behaviour 14 45.2 31 1 -
Protect oneself or seek advice family/friends/partner 6 37.5 16 0.52 (0.13–2.05) 0.347
Seek advice health centre/CAI 3 16.7 18 0.19 (0.04–0.88) 0.034
BARRIERS TO TESTING
Confidentiality testing siteb,‡ (n = 117)
Not mentioned 39 37.9 103 1 -
Mentioned 8 57.1 14 2.30 (0.71–7.50) 0.167
Fear for stigmab,§ (n = 125)
Not mentioned 35 37.6 93 1 -
Mentioned 14 43.8 32 1.41 (0.60–3.33) 0.434
Logistic constraintsb, ** (n = 119)
Not mentioned 39 36.4 107 1 -
Mentioned 8 66.7 12 3.95 (1.05–14.81) 0.042
Having no signs or symptomsb
Not mentioned 38 33.6 113 1 -
Mentioned 13 81.3 16 4.33 (1.40–13.33) 0.011
Not-wanting-to-know HIV-statusb (n = 127)
Not mentioned 36 35.0 103 1 -
Mentioned 14 58.3 24 2.53 (0.93–6.86) 0.069
Distance to CAIa
≤ 25 km 71 37.0 192 1 -
> 25 km 20 60.6 33 3.15 (1.39–7.14) 0.006
Final model of factors independently associated with late presentation at HIV diagnosis (n = 123/129)
Factors OR†† (95% CI) P-value
Age
<30 years 1-
≥ 30 years 5.34 (1.70–16.76) 0.004
Sexuality
Male heterosexual 1-
Male homosexual 0.22 (0.05–0.92) 0.039
Male bisexual 2.38 (0.46–12.41) 0.302
Female 0.23 (0.05–1.06) 0.059
Perception faithfulness partner
Faithful 1-
Unfaithful/Doubting faithfulness 0.078 (0.01–0.56) 0.011
Distance to CAI
<25 km 1-
≥ 25 km 16.69 (3.02–92.11) 0.001
aData source: patient files (n = 225). bData source: questionnaires (n = 129). Missing values are deducted by subtracting the total of individuals for 
each variable to the corresponding 225 (a) or 129 (b) patients. If totals are not indicated for a variable, it has no missing values. *Adjusted for age 
group and sex. †Only those who indicated to feel at risk of HIV infection were included (n = 67). ‡Set as 'mentioned' if: confidentiality test, doubt 
correctness result, attitude personnel or being seen at site was mentioned or agreed. §Set as 'mentioned' if: fear of loosing partner/family/job/
children or fear for rejection was mentioned or agreed. **Set as 'mentioned' if: no time, inconvenient location, no transport money, costs treatment 
or costs test was mentioned or agreed. ††Adjusted for SES, having an HIV+ partner, total-HIV-knowledge score, testing as part of screening and the 
other variables in this model. OR, odds ratio; CI, confidence interval.AIDS Research and Therapy 2008, 5:6 http://www.aidsrestherapy.com/content/5/1/6
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found, while mentioning not-wanting-to-know their HIV
status as a barrier showed a positive association and men-
tioning fear to be diagnosed positive or perceiving their
partner to be unfaithful a negative association with late
presentation at diagnosis. Not-wanting-to-know their
HIV-status could be related to fear for HIV-related stigma
as well as to general coping strategies to deal with a possi-
ble diagnosis of a life-threatening disease. Therefore it was
not included in the category 'fear for stigma'. Fear to be
diagnosed positive could instead be considered a proxy
for perception of risk, since persons mentioning this as a
barrier for testing were 5 times more likely to have felt at
risk (P = 0.001) and 4 times more likely to have expected
the result to be positive (P = 0.001). Of the individuals
that presented late and mentioned not-having-symptoms-
yet as a barrier, 9 (69%) had felt at risk, indicating that
feeling healthy might prevent people from converting
their perception of risk into the act of HIV-testing. Other
studies found that on average individuals who felt at risk
of HIV infection wait for a year before testing, most need-
ing a trigger [40] such as feeling ill which was the second
most important reason to get tested in one of these studies
[30].
As in other studies, we found heterosexual men more
likely to present late than women and homosexual men
[10,26-28,30]. Nevertheless, the proportion of women
and homosexual men found to present late was still 30%.
Almost one third of the women and the bi- and heterosex-
ual men were tested for HIV as part of screening, whereas
this proportion was only 9% among homosexuals. Higher
utilisation rates of health services and regular HIV screen-
ing during antenatal care could explain the lower likeli-
hood of women presenting late to diagnosis [26,28,33],
however, in our study only 5/25 early presenting women
were diagnosed during antenatal screening. In accordance
with an Italian study showing that women tested more
because of sexual contact with an HIV-infected person
[26], a quarter of the women (and homosexual men) in
our study went for an HIV test because their partner was
HIV-infected or had signs/symptoms of possible infec-
tion, while among hetero- and bisexual men, these pro-
portions were respectively 6% and 8% (data not shown).
In our study, homosexual men were wealthier, had
enjoyed higher education and had higher knowledge of
HIV/AIDS and of the PNSIDA than women and other
men. Since these factors were related to early testing in
other studies this could explain why homosexuals were
less likely to present late [26,27]. It has also been shown
that those homosexuals who are integrated into the gay
community are more likely to test for HIV [41]. Even
though our sample was not sufficiently large to analyse
each subgroup separately, our findings indicate that
women, bi-, homo-, and heterosexual men may have dif-
ferent pathways to testing and different factors related to
late presentation.
Conclusion
As observed elsewhere [12,19] the impact of ART on the
prognosis of HIV-infected individuals has not substan-
tially influenced people's behaviours and beliefs towards
HIV testing in Venezuela. Although Venezuela offers free
diagnosis and treatment as part of its National HIV Pro-
gram, an important proportion of individuals present late
for HIV diagnosis. Older age, male heterosexuality, low
education, low socio-economic status, lack of perceived
risk, barriers related to lack of knowledge and lack of
awareness of both HIV and the Program itself were impor-
tant determinants in this delay. Our study has given indi-
cations for areas of interest that should be explored
further using more in-depth qualitative studies in order to
determine what role the different components play in
HIV-testing behaviours. Nevertheless, our study shows
that even in the frame of free HIV control programs efforts
must still be directed to increase awareness of HIV/AIDS
Proportion of early and late presenters, by reason for testing Figure 1
Proportion of early and late presenters, by reason for 
testing. Screening consisted of screening at blood bank, ante-
natal and pre-surgery screening and screening as part of 
health certification; Own initiative consisted of testing because 
of curiosity, feeling at risk of HIV-infection, having had STIs, 
many sexual partners, unprotected sex, an unfaithful partner, 
or testing on advice of partner, family or friends; Health-
related consisted of referral by a health centre, the respond-
ent or partner showing HIV-related symptoms and having 
HIV-infected partners or children. *P <0.05. †Number of indi-
viduals is noted within each bar.
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and on the availability of the services offered by the HIV
Program. Moreover, the identification of specific factors
associated with delay in HIV-diagnosis per subgroup,
women, bi-, homo-, and heterosexual men, will be useful
in the development of targeted public health interven-
tions increasing the likelihood of early diagnosis, and
therefore, of the prognosis of people living with HIV/
AIDS in Venezuela and elsewhere.
Methods
Study design and site
We performed a cross-sectional survey between May and
October 2006 at the outpatient Centre of Integral Atten-
tion for STI and HIV/AIDS (CAI) in Valencia, to identify
factors influencing delay in HIV-diagnosis using a case-
case comparison. The CAI is the reference centre for the
PNSIDA in Carabobo State. This State has a population of
2 million inhabitants of which 70% live in the metropol-
itan area of Valencia, the state capital [20]. The region is
served by several public and private hospitals of various
levels and has a reported HIV-incidence of 12.24/100,000
[42] and an AIDS-related mortality of 4.76/100.000 [43].
Besides the CAI, two tertiary level hospitals located in
Valencia, are also part of the PNSIDA. Patients that are
admitted to tertiary hospitals and diagnosed with HIV are
reported to CAI. Patients with confirmed HIV-diagnosis
(Western Blot) are included in the PNSIDA and notified to
the regional Ministry of Health (INSALUD) through a
National HIV Notification Form including epidemiologi-
cal and clinical data. Risk factors and further clinical signs
are recorded in the patients' medical files.
Study population
The study population consisted of all individuals newly
diagnosed with HIV-infection at CAI between May 2005
and October 2006. We chose recently diagnosed patients
in order to minimise recall bias at the moment of inter-
view (see below). Eligible patients were assigned a unique
identification number to ensure anonymity of the col-
lected data.
Data collection
A structured questionnaire was developed to ascertain
socio-economic details and factors related to testing
behaviour. Most questions referred to the time before or
at diagnosis. The questionnaire contained pre-coded as
well as open questions, and was developed in English,
translated in to Spanish and pre-tested and adapted dur-
ing a pilot study. A social worker specialised in HIV/AIDS
counselling and a medical doctor from CAI assisted in the
development of the questionnaire and were trained to
perform the interviews. Eligible individuals attending CAI
were interviewed after being explained the purpose of the
study and obtaining oral informed consent. Question-
naires were double-checked for consistency and entered
into EPI-Info (version 6.04). Demographic and behav-
ioural characteristics and medical details were collected
from the patients' medical files.
Measures
Late presentation at diagnosis, the outcome variable, was
defined as patients classified at diagnosis with HIV dis-
ease-stage B or C according to the 1993 Centers for Dis-
ease Control and Prevention (CDC) classification
compared to patients diagnosed in disease-stage A ('early
presentation') [21]. This definition was chosen to avoid
ascertainment bias when using CD4 counts or AIDS to
define late presentation, since around 60% of individuals
do not have a CD4 count up to at least 3 months after HIV
diagnosis [4]. Moreover, differential distribution of indi-
viduals without CD4 counts introduces further bias as the
majority of these correspond to disease stage A.
Demographic characteristic
Demographic characteristic: age, marital status, number
of children, level of education, and occupation deter-
mined at HIV-diagnosis were collected from the patients'
medical files. Proxy measures of socio-economic status
(SES) were collected through interview: area of residence
(rural, urban), characteristics of residence (availability of
sanitary services and electricity, ownership, number of
bedrooms), monthly household income and number of
people living in the household. The CAI and the resi-
dences of the studied individuals were geo-located using a
handheld Global Positioning System (GPS) (Garmin GPS
12, Software 4.51, Garmin Corp.) and downloaded into a
digital map of Venezuela using Mapsource™ (Garmin
Corp). ESRI ArcMap 9.1 was used to calculate straight-line
distances from the subjects' residences to the CAI.
Behavioural characteristics
Behavioural characteristics were collected from the
patients' medical files: sexual orientation, age at first sex-
ual contact, condom use, having a steady partner and HIV-
status, alcohol use and (injecting) drug abuse. Lifetime
total number of sexual partners and casual sexual part-
ners, perceived faithfulness of their steady partner, sexual
contact with commercial sex workers and previous occur-
rence of STIs was recorded during interview.
Knowledge of HIV/AIDS
Knowledge of HIV/AIDS before HIV-diagnosis was
assessed during the interview by the following: having
ever heard of HIV/AIDS and how; a 15-item question
about HIV-transmission; and six true-or-false statements
about HIV/AIDS. A HIV-transmission-knowledge score
was calculated assigning points for each correct mode of
transmission (range 0–15). Knowledge of existence, avail-
ability and prices of HIV-tests as well as ART was assessed.
A PNSIDA awareness score was calculated adding oneAIDS Research and Therapy 2008, 5:6 http://www.aidsrestherapy.com/content/5/1/6
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point if there was awareness of: existence of test; free test-
ing; existence of treatment; free treatment; treatment
availability in Carabobo, in hospitals and at CAI. A total-
HIV/AIDS-knowledge score (maximum of 28) was calcu-
lated by adding all scores (Table 3).
Risk perception and barriers to HIV-testing
Perception of risk of HIV-infection and health-seeking
behaviour before HIV-diagnosis was assessed during the
interview, as well as the reasons why the subject did or did
not feel at risk. Regardless of their risk perception, all sub-
jects were asked whether they had perceived any barriers
to HIV-testing and a list of possible barriers was probed.
People could mention more than one barrier. Following
Awad et al. (2004), answers were classified in three main
categories: i) fear for HIV-related stigma, consisting of
"fear of loosing partner, friends and family, children or
employment" and "fear of being rejected;" ii) fear for con-
fidentiality at testing site, consisting of "fear that the test
would not be held confidential," "expecting the results
not to be correct," "worries about the attitude of the per-
sonnel at the testing site" and "fear of being seen at the
testing site"; and iii) logistical constrains, consisting of
"no time to go," "inconvenient location of testing site,"
"no money for transport costs," "not able to afford the test
or treatment." Other possible barriers not belonging to
these main categories were "not feeling at risk," "not hav-
ing symptoms," "not wanting to know their HIV status,"
"fear to be diagnosed positive" and "not knowing where
to go for HIV-test [44]." Furthermore, time and costs of
travel to the CAI were asked.
Facilitators for testing
The reason why people took an HIV-test were noted dur-
ing the interview and grouped into categories as follows:
i) Screening: blood bank, antenatal and pre-surgery
screening and screening as part of health certification; ii)
Health-related reasons: referral by a health centre, the
respondent or partner showing HIV-related symptoms
and having HIV-infected partners or children; iii) Own
initiative: testing because of curiosity, feeling at risk of
HIV-infection, having had STIs, many sexual partners,
unprotected sex, an unfaithful partner, or testing on
advice of partner, family or friends.
Analyses
Weather the interviewed sample was representative was
examined by comparing the data obtained from the
patients' medical files of interviewed and non-interviewed
subjects. Proportions were compared using x2  test, or
Fisher's exact test when appropriate, and Student t-test to
compare means. To obtain a relative measure of SES, a
weighted scoring of occupation and proxy measures of
SES was developed using principal component analysis
(PCA) [45,46], so that each individual was classified into
high or low relative wealth. Logistic regression was used to
obtain crude and adjusted (for age group [<30, ≥ 30 years]
and sex) odds ratios (OR) for socio-demographic, socio-
economic and behavioural characteristics, HIV knowl-
edge, risk perception, and barriers and facilitators for test-
ing. Significance was determined at the 5% level (P-
value<0.05) using Wald P-values. The Mantel-Haenszel
score test examined trends in ordered categorical varia-
bles. For most of the factors related to risk perception, and
barriers and facilitators for testing no adjustment was
made for additional confounders as the aim was to
describe the relative risk of factors that may be associated
to late presentation rather than to isolate the specific effect
of a particular variable. All other factors found to
approach significance (p < 0.2) after adjusting for age-
group and sex were fitted in a logistic regression model
and adjusted for confounders. Effect modification of dif-
ferent variables was analysed and resulting models com-
pared by likelihood ratio test. A final model included the
factors remaining significant after adjusting for all other
factors in the model, and the factors which substantially
changed the OR of other variables. All statistical analyses
were conducted using SPSS software (version 13.0.1;
SPSS) and Stata software (version 8.0; Stata). Ethics clear-
ance for the study was obtained from the ethics commis-
sion of INSALUD.
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